UMIPIC

UMIPIC

Buhoro Buhoro Kurekura Ubuvuzi

Ultra Minimum Incision Yihariye Imbere-Tumoral Chemo-Immuno

Umuti urwanya kanseri wakozwe no guhuza imiti ihoraho-irekura, imiti ya chimiotherapie (imiti ibiri), hamwe n’ubudahangarwa bw'umubiri yinjizwa mu kibyimba kandi igashyirwa mu kibyimba iyobowe na CT, ultrasound, cyangwa endoskopi. Umuti urwanya kanseri urekurwa buhoro buhoro mu minsi 7-20, ukica selile, wirinda ingaruka mbi z’ibiyobyabwenge ku mubiri wose no kugera ku ntego yo kurandura ikibyimba; Antigene yibibyimba yasohowe na selile kanseri yishwe nibiyobyabwenge bivanze icyarimwe, hifashishijwe imiti igabanya ubukana, ituma umubiri urinda umubiri umubiri, bityo bikagira uruhare mukurandura kanseri ya kanseri yisubiramo cyangwa metastatike. Ubuvuzi bwibanze bwibasiwe nubwicanyi hamwe no kuvura umutwe birashobora gukorwa kubibyimba bibi ndetse no gukomeretsa metastatike mubice bitandukanye byumubiri, bikwiranye nibibyimba hakiri kare, hagati, na nyuma yibibyimba bikomeye mubice byose byumubiri. Ubu buvuzi bwabonye ikoranabuhanga ryemewe mu Bushinwa, Amerika, na Ositaraliya. Kuva ikoreshwa mu 1998, imaze kuvura abarwayi ba kanseri barenga 80000 kandi igera ku bisubizo byiza byo kuvura!

Umusanzu wacu nyamukuru nuko ubuvuzi burambye-burekura buhuza ibyiza bya chimiotherapie na immunotherapie, kandi kunshuro yambere, byombi byahujwe kandi bikoreshwa mubuvuzi bwa intratumoral binyuze mubutabazi. Ihuza ubuvuzi bw’ibanze ndetse n’isi yose, kandi ikongerera igihe n’ibikorwa by’ibiyobyabwenge binyuze mu kurekura burundu ibiyobyabwenge mu kibyimba, bidakina gusa ingaruka za anticancer y’imiti y’imiti ya chimiotherapie, ahubwo binita ku ruhare rw’imiti ikingira indwara, bityo bikuzuza ibitagenda neza mu bundi buryo bwo kuvura, bitanga ibitekerezo bishya n’uburyo bwo kuvura kanseri, cyane cyane mu kugabanya ibibyimba byo hagati no gutera imbere cyane cyane; Ubuvuzi bwa UMPIC bufite inyungu zo gukoresha ikibyimba nkisoko ya antigen hamwe ninkingo ya autologique, nayo ijyanye niterambere ryubuvuzi bwihariye. Kandi ikoreshwa ku ivuriro, hapten ihujwe n’imiti ya chimiotherapie kugirango irekure irekure ivura kanseri yandura yibanze, mugihe itera ingaruka zidasanzwe, icyingenzi kikaba ari ugutera ubudahangarwa bw'umubiri, CD4, CD8, DC, T na NK, hamwe na B-selile yibibyimba autoantibodies: Antibodies to P53, P16, Cmyc, Zeta, IMPv1 ni ubwambere dusanze T na B bafite uruhare mukurwanya ubudahangarwa bw'umubiri, hamwe nibikorwa byubuvuzi byingaruka za kure kandi nubu buvuzi bwatoranijwe kugirango "Amabwiriza yubuvuzi bujyanye no kuvura indwara ziterwa na kanseri yanduye" (Ikigereranyo)

Ikinyamakuru cya Clinical Radiology, umuzingo wa 43, nimero 19, 2024, 1636-1648.

20241205094917441744

Dr.Baofa Yu nitsinda rye ubushakashatsi bwibanze bukubiyemo ibi bikurikira:

1.Kuraho ibibyimba bito birashobora kugenzurwa, hamwe nibimenyetso n'ingingo;

2.Icyerekezo cyibanze gishobora kugenzurwa, igihe cyo kubaho kwabarwayi ni kirekire;

3.Bigabanya kandi ingirabuzimafatizo yibibyimba (CTC) 80%, ingingo igomba gutangazwa;

4.Bishobora gukangura hypothalamus yo mu bwonko kugira uruhare mu kurwanya ubudahangarwa bw'umubiri, kandi muri icyo gihe, irashobora kandi gukomeza umunezero w'ubwonko n'umuziki kugira ngo uhuze kurwanya kanseri. Ingingo yararangiye, kandi umwarimu wa UCSD atanga igitekerezo cyo kuyishyikiriza ibidukikije cyangwa ubuvuzi karemano.

UMIPIC-Ubuvuzi: Ibigize ibiyobyabwenge

Adjuvant: kongera ubudahangarwa bw'umubiri kandi byihariye
Umukozi ukomeza: gufata ibintu byose murwego rwo hejuru igihe kirekire
Imiti igabanya ubukana: FDA yemeye ubutegetsi butera urupfu rwibibyimba kurekura antigene muri coagulation.

20240824104022202220

Inyungu esheshatu zingenzi zokuvura buhoro buhoro Ubuvuzi bwa Depot: kwibasirwa byibasiwe cyane, kwibasira ikibyimba, kwirinda indwara, gukingira indwara, inkingo nyinshi, kuramba, umutekano kandi neza.

Ibyiza kumababi menshi yibibyimba byo gufata
.
.
.
.
.
(6) Umutekano kandi neza.

Murugo
Imanza zisanzwe
Ibyerekeye Twebwe
Twandikire

Nyamuneka udusigire ubutumwa